新一代抗抑郁药

被引:29
作者
颜文伟
机构
[1] 上海市精神卫生中心
关键词
抗抑郁药; 疗效; 新一代; SHT; NE; SSRI; 忧郁症; 情感性精神病;
D O I
暂无
中图分类号
R971 [神经系统药物];
学科分类号
摘要
<正> 以前的抗抑郁药都是在偶然之间发现的,例如米帕明就是如此。后来研究其药理作用机制,知道关键在于增加神经元突触间隙中的两种神经递质:去甲肾上腺素(NE)和5羟色胺(5HT)。同时又发现米帕明等三环类抗抑郁药
引用
收藏
页码:304 / 307+303 +303
页数:5
相关论文
共 9 条
  • [1] Meclobemide: a review of its pharmacological properties and therapeutic use in depressed illness. Fitton A,Faulds D,Goa KL. Drugs . 1992
  • [2] Essential Psychopharmacology. Stahl SM. . 1996
  • [3] Buspirone in de-pressed outpatients: a controlled trial. Rickels K,Amsterdam J,Clary C,et al. Psychopharmacologia . 1990
  • [4] Oral S-adeno-sylmethionine in depression: a randomized.double-bline, placebo-controlled trial. Kagan BL,Sultzer DL,Rosenlicht N,et al. American Journal of Psychiatry . 1990
  • [5] SSRI: meta=analysis of efficacy and acceptability. Song F,Freemantle N,Sheldon TA,et al. British Medical Journal . 1993
  • [6] Rolipram: a new concept for the treatment of tricyclic resistant depression. Collins J,Abou Saleh MT. Journal of Drug Development . 1992
  • [7] Double-blind placebo-controlled study of mil-nacipran in hospitalized patients with major depressive disor-der. Macher JP. Neuropsychobiology . 1989
  • [8] A double-blind comparison of nefazodone, imipramine, and placebo in major depression. Fontaine R,Ontiveros A,Elie R,et al. Journal of Clinical Psychiatry . 1994
  • [9] A double-blind placebo-controlled study of Org 3770 (mirtazapine) in depressed outpatients. Claghor JL,Lessem MD. Journal of Affective Disorders . 1995